Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • netpumber
    Member
    • May 2014
    • 21

    #1

    sequence bias modeling understanding

    Hi.

    I'am new at NGS , RNA-seq and now i'm reading an article about the expression units in an RNA-seq experiment. The first method that it talks about is "Counts".

    So (as i understood) the number of reads that will be aligned in the reference gene is depended on 1) the total number of DNA fragments and 2) on the effective length of the feature (e.g reference gene). Everything is ok until here.

    Then author of the article writes:

    "If the abundance estimation method you’re using incorporates sequence bias modeling (such as eXpress or Cufflinks), the bias is often incorporated into the effective length by making the feature shorter or longer depending on the effect of the bias."
    As i told before i'm new and could not understand the meaning of the "sequence bias modeling". Does this mean that user defines a specific length (something like threshold) for the reference gene ?

    Any hint or example for understanding that method and why is not so good to use, is welcome.

    Thank you very much.
    Last edited by netpumber; 12-18-2014, 06:13 AM.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
42 views
0 reactions
Last Post SEQadmin2  
Working...